Dermapharm Holding SE - ESG Rating & Company Profile powered by AI
Full ESG analysis of Dermapharm Holding SE can be accessed by signing in. Alternative companies in the scoring industry group for Dermapharm Holding SE are displayed. The dashboard includes a Q&A table for Dermapharm Holding SE.
Dermapharm Holding SE in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.2; made up of an environmental score of 6.7, social score of 6.9 and governance score of 8.0.
7.2
High ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1737978896147)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
191 | Wockhardt Ltd | 7.3 | High |
191 | Zealand Pharma A/S | 7.3 | High |
217 | Dermapharm Holding SE | 7.2 | High |
217 | Eurofins Scientific SE | 7.2 | High |
217 | Genus PLC | 7.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1737978896147)
Frequently Asked Questions
Does Dermapharm Holding SE have an accelerator or VC vehicle to help deliver innovation?
Does Dermapharm Holding SE disclose current and historical energy intensity?
Does Dermapharm Holding SE report the average age of the workforce?
Does Dermapharm Holding SE reference operational or capital allocation in relation to climate change?
Does Dermapharm Holding SE disclose its ethnicity pay gap?
Does Dermapharm Holding SE disclose cybersecurity risks?
Does Dermapharm Holding SE offer flexible work?
Does Dermapharm Holding SE have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Dermapharm Holding SE disclose the number of employees in R&D functions?
Does Dermapharm Holding SE conduct supply chain audits?
Does Dermapharm Holding SE disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Dermapharm Holding SE conduct 360 degree staff reviews?
Does Dermapharm Holding SE disclose the individual responsible for D&I?
Does Dermapharm Holding SE disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Dermapharm Holding SE disclose current and / or historical scope 2 emissions?
Does Dermapharm Holding SE disclose water use targets?
Does Dermapharm Holding SE have careers partnerships with academic institutions?
Did Dermapharm Holding SE have a product recall in the last two years?
Does Dermapharm Holding SE disclose incidents of discrimination?
Does Dermapharm Holding SE allow for Work Councils/Collective Agreements to be formed?
Has Dermapharm Holding SE issued a profit warning in the past 24 months?
Does Dermapharm Holding SE disclose parental leave metrics?
Does Dermapharm Holding SE disclose climate scenario or pathway analysis?
Does Dermapharm Holding SE disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Dermapharm Holding SE disclose the pay ratio of women to men?
Does Dermapharm Holding SE support suppliers with sustainability related research and development?
Does Dermapharm Holding SE disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Dermapharm Holding SE reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Dermapharm Holding SE involved in embryonic stem cell research?
Does Dermapharm Holding SE disclose GHG and Air Emissions intensity?
Does Dermapharm Holding SE disclose its waste policy?
Does Dermapharm Holding SE report according to TCFD requirements?
Does Dermapharm Holding SE disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Dermapharm Holding SE disclose energy use targets?
Does Dermapharm Holding SE disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Dermapharm Holding SE have a policy relating to cyber security?
Have a different question?
Potential Risks for Dermapharm Holding SE
These potential risks are based on the size, segment and geographies of the company.
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.